VCH-916 is primarily used as an active agent in antiviral research and development, particularly in studying the inhibition of Hepatitis C Virus (HCV) replication. This compound has potential in inhibiting key viral enzymes, such as the NS5B polymerase, which helps reduce viral multiplication in the body. Additionally, studies are assessing the efficacy and safety of VCH-916 as a new treatment option for patients infected with HCV, potentially leading to more effective drugs with fewer side effects in the future.